These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12187922)

  • 1. Haptoglobin genotype and diabetic microangiopathies in Japanese diabetic patients.
    Koda Y; Soejima M; Yamagishi S; Amano S; Okamoto T; Inagaki Y; Yamada K; Kimura H
    Diabetologia; 2002 Jul; 45(7):1039-40. PubMed ID: 12187922
    [No Abstract]   [Full Text] [Related]  

  • 2. [The late diabetic syndrome and its correlations with hereditary factors].
    Kaeding A
    Folia Clin Int (Barc); 1968 Jan; 18(1):20-33. PubMed ID: 5743944
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypothesis--haptoglobin genotype and diabetic nephropathy.
    Nakhoul FM; Miller-Lotan R; Awaad H; Asleh R; Levy AP
    Nat Clin Pract Nephrol; 2007 Jun; 3(6):339-44. PubMed ID: 17525716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A common Glu298-->Asp (894G-->T) mutation at exon 7 of the endothelial nitric oxide synthase gene and vascular complications in type 2 diabetes.
    Cai H; Wang X; Colagiuri S; Wilcken DE
    Diabetes Care; 1998 Dec; 21(12):2195-6. PubMed ID: 9839121
    [No Abstract]   [Full Text] [Related]  

  • 5. Haptoglobin phenotype and vascular complications in patients with diabetes.
    Levy AP; Roguin A; Hochberg I; Herer P; Marsh S; Nakhoul FM; Skorecki K
    N Engl J Med; 2000 Sep; 343(13):969-70. PubMed ID: 11012324
    [No Abstract]   [Full Text] [Related]  

  • 6. In vivo and in vitro studies establishing haptoglobin as a major susceptibility gene for diabetic vascular disease.
    Asleh R; Levy AP
    Vasc Health Risk Manag; 2005; 1(1):19-28. PubMed ID: 17319095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [HAPTOGLOBIN POLYMORPHISM AS AN INDEPENDENT PREDICTOR OF DIABETIC NEPHROPATHY AND RETINOPATHY].
    Dahan I; Thauho N; Nakhoul F; Nakhoul N; Jabaly H; Farber E
    Harefuah; 2016 Jul; 155(7):439-442. PubMed ID: 28514126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms of the aldose reductase locus (ALR2) and susceptibility to diabetic microvascular complications.
    Patel A; Ratanachaiyavong S; Millward BA; Demaine AG
    Adv Exp Med Biol; 1993; 328():325-32. PubMed ID: 8493909
    [No Abstract]   [Full Text] [Related]  

  • 9. [Significance of familial and genetic factors for diabetic angiopathy in the micro and macrocirculation].
    Kaeding A; Bellin H; Ewald HO; Friede A; Henning L; Hasse N; Naumann G; Werner P; Wilmbusse H; Wüstenberg PW
    Z Gesamte Inn Med; 1972 Oct; 27(19):826-9. PubMed ID: 4647367
    [No Abstract]   [Full Text] [Related]  

  • 10. [Genetic risk factors for diabetic complications].
    Deutsch E; Vardi P; Shohat M
    Harefuah; 1997 Jun; 132(12):862-6. PubMed ID: 9264195
    [No Abstract]   [Full Text] [Related]  

  • 11. [Genetic factors for diabetic microvascular complications].
    Yasuda K
    Nihon Rinsho; 2010 Nov; 68 Suppl 9():70-4. PubMed ID: 21661145
    [No Abstract]   [Full Text] [Related]  

  • 12. [Possible genetic causes for late complications of diabetes mellitus].
    Klemm T; Paschke R
    Med Klin (Munich); 2000 Jan; 95(1):31-9. PubMed ID: 10668342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 20210 G to A prothrombin polymorphism and late complications in type 1 diabetes mellitus.
    Humpert PM; Isermann B; Rudofsky G; Ziegler R; Bierhaus A; Ritz E; Nawroth PP
    Thromb Haemost; 1999 Jan; 81(1):164. PubMed ID: 10348712
    [No Abstract]   [Full Text] [Related]  

  • 14. Association between a polymorphism in the angiotensin-converting enzyme gene and microvascular complications in Japanese patients with NIDDM.
    Doi Y; Yoshizumi H; Yoshinari M; Iino K; Yamamoto M; Ichikawa K; Iwase M; Fujishima M
    Diabetologia; 1996 Jan; 39(1):97-102. PubMed ID: 8720609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haptoglobin genotype as a risk factor for diabetic retinopathy.
    Nakhoul FM; Marsh S; Hochberg I; Leibu R; Miller BP; Levy AP
    JAMA; 2000 Sep; 284(10):1244-5. PubMed ID: 10979109
    [No Abstract]   [Full Text] [Related]  

  • 16. [Genetic susceptibility to microangiopathy development in Type 1 diabetes mellitus].
    Corrêa-Giannella ML; Vieira SM
    Arq Bras Endocrinol Metabol; 2008 Mar; 52(2):375-86. PubMed ID: 18438549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MTHFR gene polymorphism is susceptible to diabetic retinopathy but not to diabetic nephropathy in Japanese type 2 diabetic patients.
    Maeda M; Yamamoto I; Fukuda M; Motomura T; Nishida M; Nonen S; Fujio Y; Kasayama S; Azuma J
    J Diabetes Complications; 2008; 22(2):119-25. PubMed ID: 18280442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of Toll-like receptor 4 gene polymorphism on vascular complications in type 2 diabetes patients.
    Buraczynska M; Zukowski P; Ksiazek K; Wacinski P; Dragan M
    Diabetes Res Clin Pract; 2016 Jun; 116():7-13. PubMed ID: 27321310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diabetic microangiopathy: does a genetic susceptibility HLA-correlated exist?].
    Scaldaferri E; Devidè A
    Minerva Endocrinol; 1985; 10(2):115-24. PubMed ID: 3906376
    [No Abstract]   [Full Text] [Related]  

  • 20. The Haptoglobin genotype predicts cardio-renal mortality in type 1 diabetes.
    Costacou T; Orchard TJ
    J Diabetes Complications; 2016 Mar; 30(2):221-6. PubMed ID: 26684170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.